FDA okays start of BrainStorm stem cell trial in ALS patients

BrainStorm Cell Therapeutics said the U.S. Food and Drug Administration approved the start of a mid-stage clinical trial of its adult stem cell treatment for patients with amyotrophic lateral sclerosis .

http://ift.tt/1itw3Ob